• +86-0635-6175299
  • li_ye@inyelchem.com
    •
  • dettagli azienda

     Shandong Haohong Biotechnology Co., Ltd.

     [Shandong,China]

    Attività di tipo:fabbricante

    I mercati principali: Americas , Asia , Europa dell'est , Europa , Medio Oriente , Nord Europa , Europa occidentale , In tutto il mondo

    esportatore:71% - 80%

    Karts:Test Report, ISO9001

    Language

 Shandong Haohong Biotechnology Co., Ltd.

Tutti
  • Tutti
  • Titolo
Tutti
  • Tutti
  • Titolo
Casa> Blog
May 28, 2021
Coronavirus (COVID-19) Update: FDA Authorizes Additional Monoclonal Antibody for Treatment of COVID-19

Today, the U.S. Food and Drug Administration issued an 

vedi di più >>
May 25, 2021
FDA Approves First Targeted Therapy for Subset of Non-Small Cell Lung Cancer

Today, the U.S. Food and Drug Administration

vedi di più >>
May 19, 2021
FDA approves enzalutamide for metastatic castration-sensitive prostate cancer

On December 16, 2019, the Food and Drug Adm

vedi di più >>
May 19, 2021
Coronavirus (COVID-19) Update: FDA Authorizes Drug Combination for Treatment of COVID-19

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination

vedi di più >>
May 19, 2021
FDA approves larotrectinib for solid tumors with NTRK gene fusions

On November 26, 2018, the Food and Drug Administration granted accelerated approval to larotrectinib (VIT

vedi di più >>
April 01, 2021
COVID-19 Vaccine: Surmounting Prejudices and Other Roadblocks

Against all odds and contrary to expectations, Nigeria recently joined a few other African

vedi di più >>
April 01, 2021
UCSF and MGH: Apalutamide Delays Progression of Nonmetastatic, Castration-Resistant Prostate Cancer

BOSTON and 

vedi di più >>
April 01, 2021
FDA approves new treatment for a type of late stage prostate cancer

The U.S. Food and Drug Administration today approved Xtandi (enzalutamide) to treat

vedi di più >>
April 01, 2021
Enzalutamide

Enzalutamide (Xtandi

vedi di più >>
April 01, 2021
Enzalutamide or abiraterone?

Enzalutamide and abiraterone are both types of hormone therapy that treat advanced prostate cancer.

vedi di più >>
 Shandong Haohong Biotechnology Co., Ltd.

Contattaci

Kelly
Nome: Ms. Kelly
E-mail: li_ye@inyelchem.com
Numero Di Telefono: +86-0635-6175299
Azienda Indirizzo No.5,North Guandao street,Gaotang County, Liaocheng, Shandong

mobile Site

Copyright © 2024  Shandong Haohong Biotechnology Co., Ltd. All rights reserved .  Privacy Policy

Casa

Product

Phone

Chi siamo

inchiesta
Please Leave Us A Message

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Allegato di caricamento
Invia